Safety Study of allogenic hiPSC-retinas in Retinitis Pigmentosa

General Information

Clinical trials phase Phase 1
Start date (estimated) 2020-10-05
Clinical feature
Label retinitis pigmentosa
Link http://purl.obolibrary.org/obo/DOID_10584
Description A retinal degeneration characterized by the gradual deterioration of the photoreceptors or the retinal pigment epithelium of the retina leading to progressive sight loss.; Xref MGI. OMIM mapping confirmed by DO. [LS].

Administrative Information

ICTRP weblink https://trialsearch.who.int/Trial2.aspx?TrialID=JPRN-jRCTa050200027
Other study identifiers
Name jRCTa050200027
Description Japan Registry of Clinical Trials (jRCT)
Source weblink https://jrct.niph.go.jp/en-latest-detail/jRCTa050200027
Public contact
Email e_jrct@kcho.jp
Public email e_jrct@kcho.jp
First name Shigeki
Last name Yamasaki
Phone +81-78-381-9876
City Kobe
Country
Japan
Address freetext 2-1-8 Minatojima-minamimachi, Chuo-ku, Kobe Hyogo, Japan

Cells

Which differentiated cell type is used
Label retina
Link http://purl.obolibrary.org/obo/UBERON_0000966
Description The retina is the innermost layer or coating at the back of the eyeball, which is sensitive to light and in which the optic nerve terminates.

Recruitment

Recruitment Status Recruiting
Estimated number of participants 2
Contact institutions/departments